Cytogenetic, morphologic and oncogene analysis of a cell line derived from a heterologous mixed mullerian tumor of the ovary

In Vitro Cellular and Developmental Biology - Animal

Volumn 33, Issue 5, 1997, Pages 325-331

  Becker, Jeanne L ^a   Papenhausen, Peter R ^d   Widen, Raymond H ^b,c  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c TAMPA GENERAL HOSPITAL   (United States)

^d Department of Molecular Genetics ^*  (United States)

Author keywords

Cytogenetics; Mixed mullerian tumor; Oncogene

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE;

ARTICLE; CARCINOGENESIS; CHROMOSOME ABERRATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; KARYOTYPE; MIXED MULLERIAN TUMOR; OVARY TUMOR; TUMOR BIOPSY; TUMOR CELL CULTURE; TUMOR SUPPRESSOR GENE;

EID: 0030977671     PISSN: 10712690     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11626-997-0001-x     Document Type: Article

References (39)

1. Atkin, N. B.; Baker, M. C. Abnormal chromosomes including small metacentrics in 14 ovarian cancers. Cancer Genet. Cytogenet. 26:355-361; 1987.
2. Becker, J. L.; Prewett, T. L.; Spaulding, G. F., et al. Three-dimensional growth and differentiation of ovarian tumor cell line in high aspect rotating-wall vessel: morphologic and embryologic considerations. J. Cell. Biochem. 51:283-289; 1993.
3. Berchuck, A.; Kamel, A.; Whitaker, R., et al. Overexpression of HER-2/ neu is associated with poor survival in advanced epithelial ovarian cancer. Cancer Res. 50:4087-4091; 1990.
4. Centola, G. M. Long-term growth of a heterologous mixed mullerian tumor of the ovary. Invasion and Metastasis 6:123-132; 1986.
5. Chung, M.-T.; Mukai, K.; Teshima, S., et al. Expression of various antigens by different components of uterine mixed mullerian tumors: an immunohistochemical study. Acta Pathol. Jpn. 38:35-45; 1988.
6. Dehner, L. P.; Norris, H. J.; Taylor, H. B. Carcinosarcomas and mixed mesodermal tumors of the ovary. Cancer 27:207-216; 1971.
7. Dinh, T. V.; Slavin, R. E.; Bhagavan, B. S., et al. Mixed mesodermal tumors of the ovary: a clinicopathologic study of 14 cases. Obstet. Gynecol. 72:409-412; 1988.
8. Emoto, M.; Iwasaki, H.; Kikuchi, M., et al. Two cell lines established from mixed mullerian tumors of the uterus. Morphologic, immunocytochemical and cytogenetic analysis. Cancer 59:1759-1768; 1991.
9. Fujita, H.; Wake, N.; Kutsuzawa, T., et al. Marker chromosomes of the long arm of chromosome 1 in endometrial carcinoma. Cancer Genet. Cytogenet. 18:283-293; 1985.
10. Geisinger, K. R.; Dabbs, D. J.; Marshall, R. B. Malignant mixed mullerian tumors. An ultrastructural and immunohistochemical analysis with histogenetic considerations. Cancer 59:1781-1790; 1987.
11. Goodwin, T. J.; Prewett, T. L., Spaulding, G. F., et al. Three-dimensional culture of a cell line from mixed mullerian tumor of the ovary: expression of in vivo characteristics. In Vitro Cell. Dev. Biol. 33:366-374, 1997.
12. Hanjani, P.; Petersen, R. O.; Lipton, S. E., et al. Malignant mixed mesodermal tumors and carcinosarcoma of the ovary: report of eight cases and review of literature. Obstet. Gyncol. Surv. 38:537-545; 1983.
13. Hill, R. P.; Miller, F. M. Combined mesenchymal sarcoma and carcinoma (carcinosarcoma) of the uterus. Cancer 4:803-816; 1951.
14. Ishiwata, I.; Ishiwata, C.; Nagayama, T., et al. Histogenesis and culture of human uterine carcinosarcoma. Cancer Res. 41:1978-1983; 1981.
15. Kacinski, B. M.; Carter, D.; Kohorn, E. I., et al. Oncogene expression in vivo by ovarian adenocarcinoma and mixed-mullenan tumors. Yale J. Biol. Med. 62:379-392; 1989.
16. Karager, S. Standing Committee of Human Cytogenetic Nomenclature. ISCN; An international system for human cytogenetic nomenclature Basel; 1985: 6-42.
17. Krishan, A. A rapid flow cytometric analysis of mammalian cell cycle by propidium iodide. J. Cell Biol. 66:188-193; 1975.
18. Kupryjanczyk, J.; Thor, A. D.; Beauchamp, R., et al. p53 gene mutations and protein accumulation in human ovarian cancer. Proc. Natl. Acad. Sci. USA 90:4961-4965; 1993.
19. Marks, J. R.; Davidoff, A. M.; Kerns, B. J., et al. Overexpression and mutation of p53 in epithelial ovarian cancer. Cancer Res. 51:2979-2984; 1991.
20. Masuda, A.; Takeda, A.; Fukami, H., et al. Characteristics of cell lines established from a mixed mesodermal tumor of the human ovary. Carcinomatous cells are changeable to sarcomatous cells. Cancer 60:2696-2703; 1987.
21. Mever, R. Mischgeschwulste des uterus: die komplizierten tumoren. In: Henke, F.; Lubarsch, O., eds. Handbuch der speziellen pathologischen anatomie und histologie. Vol. 7. Berlin, Germany: Julius Springer; 1930:412-415.
22. Mitelman, F. In: catalog of chromosome aberrations in cancer. Third Ed., New York: Alan R. Liss; 1988.
23. Morrow, C. P.; d'Ablaing, G.; Brady, L. W., et al. A clinical and pathologic study of 30 cases of malignant mixed mullerian epithelial and mesenchymal ovarian tumors: a gynecologic oncology group study. Gynecol. Oncol. 18:278-292; 1984.
24. Nilbert, M.; Jin, Y.; Heim, S., et al. Chromosome rearrangements in two uterine sarcomas. Cancer Genet. Cytogenet. 44:27-35; 1990.
25. Noorduyn, L. A.; Herman, C. J. The relation between mixed mesodermal tumors and adenocarcinomas of the ovary. An immunopathologic study. Eur. J. Cancer and Clin. Oncol. 23:157-162; 1987.
26. Ober, W. B. Uterine sarcomas: histogenesis and taxonomy. Ann. N.Y. Acad. Sci. 75:568-585; 1959.
27. Ono, I.; Ishiwata, I.; Tashiro, A., et al. Establishment and characterization of two human mixed mesodermal tumor cell lines from the same patient. J. Natl. Cancer Inst. 72:1241-1252; 1981.
28. Pejovic, T.; Heim, S.; Mandahl, M., et al. Complex karyotypic anomalies, including an i(5p) marker chromosome, in malignant mixed mesodermal tumor of the ovary. Cancer Genet. Cytogenet. 46:65-69; 1990.
29. Puts, J. J.; Moesker, O.; Aldeweireldt, J., et al. Application of antibodies to intermediate filament proteins in simple and complex tumors of the female genital tract. Int. J. Gynecol. Pathol. 6:257-274; 1987.
30. Ramaekers, F. C. S.; Verheijen, R. H. M.; Moesker, O., et al. Mesodermal mixed tumor. Diagnosis by analysis of intermediate filament proteins. Am. J. Surg. Pathol. 7:381-385; 1983.
31. Scambia, G.; Catozzi, L.; Panici, P. B., et al. Expression of ras oncogene p21 in normal and neoplastic ovarian tissues: correlation with histopathologic features and receptors for estrogen, progesterone, and epidermal growth factor. Am. J. Obstet. Gynecol. 168:71-78; 1993.
32. Schmid, I.; Uittenbogaart, C. H.; Giorgi, J. V. A gentle fixation and permeabilization method for combined cell surface and intracellular staining with improved precision in DNA quantification. Cytometry 12:279-285; 1991.
33. Seabright, M. A rapid banding technique for human chromosomes. Lancet ii:971-972; 1971.
34. Slamon, D. J.; Godolphin, W.; Jones, L. A., et al. Studies of the HER-2/ neu proto-oncogene in human breast and ovarian cancer. Science 244:707-712; 1989.
35. Takeda, A.; Matsuyama, M.; Kuzuya, K., et al. Mixed mesodermal tumor of the ovary with carcinomembryonic antigen and alkaline phosphatase production. Histochemical autoradiographic and electron microscopic studies of heterotransplanted tumors in athymic nude mice. Cancer 53:103-112; 1984.
36. Thor, A.; Gorstein, F.; Ohuchi, N., et al. Tumor associated glycoprotein (TAG-72) in ovarian carcinomas defined by monoclonal antibody B72.3. J. Natl. Cancer Inst. 76:995-1006; 1986.
37. van Haaften-Day, C.; Russel, P.; Brammah-Carr, S. Two homologous mixed mullerian tumor lines of the ovary and their characteristics. Cancer 65:1753-1761; 1990.
38. van Niekerk, C. C.; Jap, P. H. K.; Thomas, C. M. G., et al. Marker profile of mesothelial cells versus ovarian carcinoma cells. Int. J. Cancer 43:1065-1071; 1989.
39. Whang-Peng, J.; Knutsen, T.; Douglass, E. C., et al. Cytogenetic studies in ovarian cancer. Cancer Genet. Cytogenet. 11:91-106; 1984.